Combining fMRI with a pharmacokinetic model to determine which brain areas activated by painful stimulation are specifically modulated by remifentanil (Q38487754): Difference between revisions
Jump to navigation
Jump to search
Added reference to claim: main subject (P921): pharmacokinetics (Q323936), batch #229276 |
Research Bot (talk | contribs) Added reference to claim: main subject (P921): functional magnetic resonance imaging (Q903809), batch #237395 |
||
| (One intermediate revision by the same user not shown) | |||
| Property / main subject | |||
| Property / main subject: functional magnetic resonance imaging / rank | |||
Normal rank | |||
| Property / main subject: functional magnetic resonance imaging / reference | |||
Latest revision as of 08:16, 11 September 2024
scientific article published on August 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combining fMRI with a pharmacokinetic model to determine which brain areas activated by painful stimulation are specifically modulated by remifentanil |
scientific article published on August 2002 |
Statements
1 reference
Combining fMRI with a pharmacokinetic model to determine which brain areas activated by painful stimulation are specifically modulated by remifentanil (English)
1 reference
Richard G Wise
1 reference
Richard Rogers
1 reference
Deborah Painter
1 reference
Susanna Bantick
1 reference
Alexander Ploghaus
1 reference
Pauline Williams
1 reference
Garth Rapeport
1 reference
Irene Tracey
1 reference
1 August 2002
1 reference
1 reference
16
1 reference
4
1 reference
999-1014
1 reference
Identifiers
1 reference
1 reference
28 January 2021
1 reference